SULT2B10 Inhibitors

Chemical inhibitors of SULT2B10 encompass a range of compounds that directly impede the enzyme's sulfonation activity. Triclosan, for instance, can bind to the sulfotransferase domain of SULT2B10, which prevents the necessary binding of endogenous substrates for sulfonation, leading to inhibition. Similarly, Bisphenol A, by interacting with the active site of the enzyme, obstructs the natural substrates from binding, thus inhibiting the enzyme's function. Compounds like Quercetin, Chrysin, and Apigenin serve as competitive inhibitors; they occupy the active site of SULT2B10, thereby preventing the sulfonation of the intended substrates. This competition ensures that the enzyme's activity is reduced as these molecules mimic the structure of the natural substrates to varying degrees, leading to a decrease in the sulfonation function of SULT2B10.

Further inclusion of Kaempferol, Resveratrol, and Ellagic Acid adds to the spectrum of chemical inhibitors by binding to the same active site, each reducing the ability of SULT2B10 to catalyze the transfer of sulfate groups to its substrates. Genistein, Biochanin A, and Naringenin also inhibit SULT2B10 by competing with natural substrates, thus impeding the normal sulfotransferase activity. Curcumin, with its distinct molecular structure, can also bind to the active site of SULT2B10, which obstructs the access of endogenous substrates and inhibits the enzyme's functionality. Each of these chemicals, through their interaction with the active site and competition with endogenous substrates, ensures that the sulfonation activity - vital to the function of SULT2B10 - is effectively inhibited.